Emily J Godbout1, Amy L Pakyz2, John Daniel Markley3, Andrew J Noda4, Michael P Stevens3. 1. Department of Pediatrics, Division of Pediatric Infectious Diseases, Children's Hospital of Richmond at Virginia Commonwealth University Health System, Children's Pavilion, 1000 East Broad St, PO Box 23298-0163, Richmond, VA, USA. emily.godbout@vcuhealth.org. 2. Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University, Richmond, VA, USA. 3. Department of Internal Medicine, Division of Infectious Disease, Veterans Affairs Medical Center, Virginia Commonwealth University Health System, Richmond, VA, USA. 4. Department of Pharmacy, Virginia Commonwealth University Health System, Richmond, VA, USA.
Abstract
PURPOSE OF REVIEW: We aim to systematically review the literature on the effectiveness of pediatric antimicrobial stewardship programs (ASPs) and antimicrobial stewardship (AS) strategies in the United States (US) inpatient setting. Furthermore, we review current gaps and challenges for unique pediatric populations and those in ambulatory settings. RECENT FINDINGS: Misuse and overuse of antimicrobials have been identified as key factors for antimicrobial resistance (AR). Multiple professional organizations support the implementation of hospital-based ASPs to decrease antimicrobial consumption, improve patient outcomes, and reduce healthcare costs. There is limited data on the effectiveness of inpatient pediatric ASPs and AS strategies in unique populations. Furthermore, there is a paucity of evidence on ASPs in ambulatory settings. This review contributes to the growing body of evidence that supports the use of pediatric ASPs to optimize antimicrobial therapy in the inpatient setting as well as in unique patient populations and ambulatory settings. Active stewardship is critical and antimicrobial consumption is a key outcome metric for programs.
PURPOSE OF REVIEW: We aim to systematically review the literature on the effectiveness of pediatric antimicrobial stewardship programs (ASPs) and antimicrobial stewardship (AS) strategies in the United States (US) inpatient setting. Furthermore, we review current gaps and challenges for unique pediatric populations and those in ambulatory settings. RECENT FINDINGS: Misuse and overuse of antimicrobials have been identified as key factors for antimicrobial resistance (AR). Multiple professional organizations support the implementation of hospital-based ASPs to decrease antimicrobial consumption, improve patient outcomes, and reduce healthcare costs. There is limited data on the effectiveness of inpatient pediatric ASPs and AS strategies in unique populations. Furthermore, there is a paucity of evidence on ASPs in ambulatory settings. This review contributes to the growing body of evidence that supports the use of pediatric ASPs to optimize antimicrobial therapy in the inpatient setting as well as in unique patient populations and ambulatory settings. Active stewardship is critical and antimicrobial consumption is a key outcome metric for programs.
Authors: Joshua Wolf; Yilun Sun; Li Tang; Jason G Newland; Jeffrey S Gerber; Christie J Van Dyke; Saul R Hymes; Diana Yu; Delia C Carias; Penelope A Bryant Journal: Infect Control Hosp Epidemiol Date: 2015-12-07 Impact factor: 3.254
Authors: Lori Rutman; Davene R Wright; James OʼCallaghan; Suzanne Spencer; K Casey Lion; Matthew P Kronman; Chuan Zhou; Rita Mangione-Smith Journal: J Healthc Qual Date: 2017 Jul/Aug Impact factor: 1.095
Authors: Joseph Schulman; Robert J Dimand; Henry C Lee; Grace V Duenas; Mihoko V Bennett; Jeffrey B Gould Journal: Pediatrics Date: 2015-04-20 Impact factor: 7.124
Authors: Rachael K Ross; Jonathan M Beus; Talene A Metjian; A Russell Localio; Eric D Shelov; Bimal R Desai; Sean P O'Neill; Theoklis E Zaoutis; Jeffrey S Gerber Journal: Infect Control Hosp Epidemiol Date: 2016-05-13 Impact factor: 3.254
Authors: Adam L Hersh; Stephen A De Lurgio; Cary Thurm; Brian R Lee; Scott J Weissman; Joshua D Courter; Thomas V Brogan; Samir S Shah; Matthew P Kronman; Jeffrey S Gerber; Jason G Newland Journal: Pediatrics Date: 2014-12-08 Impact factor: 7.124
Authors: David F Gaieski; Mark E Mikkelsen; Roger A Band; Jesse M Pines; Richard Massone; Frances F Furia; Frances S Shofer; Munish Goyal Journal: Crit Care Med Date: 2010-04 Impact factor: 7.598
Authors: Amanda L Hurst; Daniel Olson; Stig Somme; Jason Child; Laura Pyle; Daksha Ranade; Alexandra Stamatoiu; Timothy Crombleholme; Sarah K Parker Journal: J Pediatric Infect Dis Soc Date: 2017-03-01 Impact factor: 3.164
Authors: R Brigg Turner; Elena Valcarlos; Ann M Loeffler; Michael Gilbert; Dominic Chan Journal: J Pediatric Infect Dis Soc Date: 2017-09-01 Impact factor: 3.164
Authors: Scott L Weiss; Mark J Peters; Waleed Alhazzani; Michael S D Agus; Heidi R Flori; David P Inwald; Simon Nadel; Luregn J Schlapbach; Robert C Tasker; Andrew C Argent; Joe Brierley; Joseph Carcillo; Enitan D Carrol; Christopher L Carroll; Ira M Cheifetz; Karen Choong; Jeffry J Cies; Andrea T Cruz; Daniele De Luca; Akash Deep; Saul N Faust; Claudio Flauzino De Oliveira; Mark W Hall; Paul Ishimine; Etienne Javouhey; Koen F M Joosten; Poonam Joshi; Oliver Karam; Martin C J Kneyber; Joris Lemson; Graeme MacLaren; Nilesh M Mehta; Morten Hylander Møller; Christopher J L Newth; Trung C Nguyen; Akira Nishisaki; Mark E Nunnally; Margaret M Parker; Raina M Paul; Adrienne G Randolph; Suchitra Ranjit; Lewis H Romer; Halden F Scott; Lyvonne N Tume; Judy T Verger; Eric A Williams; Joshua Wolf; Hector R Wong; Jerry J Zimmerman; Niranjan Kissoon; Pierre Tissieres Journal: Intensive Care Med Date: 2020-02 Impact factor: 17.440
Authors: Roberta Crevelário de Melo; Bruna Carolina de Araújo; Maritsa Carla de Bortoli; Tereza Setsuko Toma Journal: Rev Panam Salud Publica Date: 2020-09-23
Authors: Charlotte Z Woods-Hill; Anping Xie; John Lin; Heather A Wolfe; Alex S Plattner; Sara Malone; Kathleen Chiotos; Julia E Szymczak Journal: JAC Antimicrob Resist Date: 2022-01-22